Plant Project Evonik Expands Capacities for Isophorone and Derivatives

Editor: Dominik Stephan

German speciality chemcals company Evonik boosts its global production capacities for isophorone (IP) and isophorone diamine (IPD) with an € 100 million dollar investment in Shanghai. There, the company builds a new production site, scheduled to go onstream in 2014...

Related Vendors

(Picture: Evonik)

Shanghai/PR China – “We're investing in China, because we are committed to the growth region Asia. As a world leader in isophorone-based products, we will continue to further consolidate and expand our position in this chemistry," says Dr. Ulrich Küsthardt, President of Evonik’s Coating & Additives Business Unit.

The company underlined its strategy to establish a presence in proximity to customers in key growth areas, such as Asia: “Our aim in building the plants in Shanghai—at the company’s existing multi-user site—is to supply our Asian customers with the same high-quality products they are used to from our plants in Europe and the USA, now from a plant in the region," says Gerd Brand, Senior Vice President and Head of Crosslinkers Business Line.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent